Lantheus Holdings, Inc. (LNTH)
63.10
+2.28
(+3.75%)
USD |
NASDAQ |
Dec 11, 16:00
63.23
+0.13
(+0.21%)
After-Hours: 20:00
Lantheus Holdings Research and Development Expense (Quarterly): 48.02M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Cytokinetics, Inc. | 96.55M |
| Integra LifeSciences Holdings Corp. | 20.42M |
| Iovance Biotherapeutics, Inc. | 75.17M |
| Tandem Diabetes Care, Inc. | 47.88M |
| Day One Biopharmaceuticals, Inc. | 31.42M |